Search for: "Johnson v. Merck, Sharp " Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Dec 2008, 11:40 am
Court of Appeal (Civil Division) MA v Merck Sharp & DOHME Ltd [2008] EWCA Civ 1426 (16 December 2008) Animatrix Ltd & Ors v O’Kelly [2008] EWCA Civ 1415 (16 December 2008) Calvert v William Hill Credit Ltd [2008] EWCA Civ 1427 (16 December 2008) Allan v Johnson Controls Automative (UK) Ltd [2008] EWCA Civ 1377 (16 December 2008) Smith [...] [read post]
21 Nov 2012, 5:00 am by Bexis
Merck Sharp & Dohme Corp., 807 N.W.2d 343, 347 (Mich. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Teva and ratiopharm (EPLAW) Fentanyl – Germany: Federal Court of Justice: Lessons to be learned for claim construction and novelty: Xa ZR 149/07 (Kluwer Patent Blog) Finasteride – France: Tribunale de Grande Instance de Paris: Murder me twice – Merck’s dosage regime patent held invalid again: Teva v Merck Sharp & Dohme (EPLAW) Gaviscon (Sodium alginate, Sodium bicarbonate, Calcium carbonate) – UK: Reckitt Benckiser fined… [read post]
3 Aug 2011, 3:31 am by Marie Louise
  General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
28 Jun 2010, 3:08 am
 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
27 Jun 2010, 6:00 pm by Duncan
 Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
11 Nov 2010, 12:54 pm by Bexis
Merck & Co., 2003 WL 22902622, at *3 n.3 (E.D. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]